George Soros's APGE Position Overview
George Soros (via Soros Fund Management LLC) currently holds 0 shares of Apogee Therapeutics, Inc. (APGE) worth $0, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, George Soros has initiated a new position in APGE, representing a fresh investment thesis on this company. Largest reduction occurred in Q3 2026, reducing 564,500 shares.
Analysis based on 13F filings available since 2013 Q2
George Soros's Apogee Therapeutics (APGE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Apogee Therapeutics (APGE) Trades by George Soros
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | -564,500 | Sold Out | 0 | $0.00 |
| Q2 2026 | +564,500 | New Buy | 564,500 | $132.73 |
George Soros's Apogee Therapeutics Investment FAQs
George Soros first purchased Apogee Therapeutics, Inc. (APGE) in Q2 2026, acquiring 564,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
George Soros has held Apogee Therapeutics, Inc. (APGE) for 2 quarters since Q2 2026.
George Soros's largest addition to Apogee Therapeutics, Inc. (APGE) was in Q2 2026, adding 564,500 shares worth $74.93 M.
According to the latest 13F filing for Q3 2026, George Soros's firm, Soros Fund Management LLC, owns 0 shares of Apogee Therapeutics, Inc. (APGE), valued at approximately $0.
As of the Q3 2026 filing, Apogee Therapeutics, Inc. (APGE) represents approximately 0.00% of George Soros's publicly disclosed stock portfolio, making it one of their key holdings.
George Soros's peak holding in Apogee Therapeutics, Inc. (APGE) was 564,500 shares, as reported at the end of Q2 2026.